015), and 25 out of 33 patients (76%) had an increase in their platelet counts
Researchers at the National Institutes of Health (NIH) are studying if the medication
Danazol also depresses the preovulatory surge in output of follicle-stimulating hormone (FSH) and luteinizing hormone (LH), thereby reducing ovarian estrogen production
In a phase 1–2 prospective study involving patients with telomere diseases, we administered the synthetic sex hormone danazol orally at a dose of 800 mg per day for a total of 24 months The efficacy of danazol was assessed in 50 patients with myelofibrosis and anemia using the recently revised criteria of the International Working Group for Myelofibrosis Research and Treatment
Aims: To assess the efficacy and safety of danazol in improving the platelet count in low risk MDS pts with severe thrombocytopenia
This allows them to make blood cells for longer
Purpose To study the potential utility of danazol for treating patients with myelodysplastic syndromes, with a focus on efficacy and adverse effects (AEs)
Cytogenetic studies revealed the presence of two abnormal clones
Moderate to Severe Disease or Patients Infertile due to Endometriosis: Initial dose: 800 mg orally per day, given in 2 divided doses
She received a Bachelor’s Degree at the University of California, San Diego in 1999 and a Master’s Degree in Epidemiology from the University of Edinburgh, Scotland in 2002
It is taken by mouth
Platelets are disc-shaped elements in the blood that assist in blood clotting